Impact Factor
3.73
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.39
1,820 total citations
h5-index
42
h5 depth signal
Cited share
71.1%
397 of 558
Total citations
1,820
Citation footprint
Metric signal
3.93
External metric anchor
Self-citation
5.3%
96 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
994
United Kingdom
469
Japan
286
Canada
264
China
227
Citing Fields of Research
Oncology
643
Musculoskeletal & Nerve Cancer
410
Breast Cancer
277
Liver & Colon Cancer
232
Reproductive Health
195
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
11,330
Articles tracked across the journal lifetime
Indexed publication set
558
397 cited publications
Last 12 months
290
24.2 publications/month
Open access share
36.9%
107 OA publications in the last year
Leading citing country
United States
994 citing publications
Leading citing field
Oncology
643 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1,Jan. 1977-
v1,Jan. 1977-
Active Coverage
Research Focus & Classification
Indexed Subjects
Breast Cancer
Oncology
Musculoskeletal & Nerve Cancer
Urology
Liver & Colon Cancer
Testicular Disorders
Digestive Disorders
Issuing & Sponsoring Bodies
Contributor
International Academy of Pathology. British Division
Broad Categories
Pathology
Musculoskeletal & Nerve Cancer
Breast Cancer
Liver & Colon Cancer
Urology
Lymphomas
Reproductive Health
Lung Cancer
MeSH Descriptors
Histology
Pathology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/his.70303
Open DOI
Characterization of the morphological, immunophenotypical and cytogenetic features of high‐grade B‐cell lymphoma with 11q aberration
Aims: High‐grade B‐cell lymphoma with 11q aberration is a rare neoplasm of mature B‐cell lineage, and large‐scale clinicopathological studies of this disease remain scarce. To bridge this research gap, we conducted a retrospective analys...
02
DOI 10.1111/his.70281
Open DOI
Pathological assessment of neoadjuvant‐treated melanoma specimens: a historical overview, lessons learned along the way and the road ahead
Neoadjuvant therapy has been recently established as the standard of care in surgically resectable stage III melanoma. Insofar as the extent of tumour response correlates with metrics of patient survival, this underscores the critical on...
03
DOI 10.1111/his.70302
Open DOI
Alveolar soft part sarcoma of the female genital tract: a clinicopathological and molecular genetic study of 26 cases
Aims: Occurrence of alveolar soft part sarcoma (ASPS) in the female genital tract is extremely rare. We report 26 cases of ASPS arising in the female genital tract to further characterize its clinicopathological and molecular features, d...
04
DOI 10.1111/his.70300
Open DOI
Detection of NTRK1/2/3 rearrangements in pigmented spindle cell naevus of Reed: a comparative study of optimized pan‐ TRK immunohistochemistry, FISH and RNA ‐ NGS
Aims: Pigmented spindle cell naevus of Reed (PSCN) is mainly characterized by MYO5A::NTRK3 fusion. However, the prevalence of NTRK fusions/rearrangements in PSCNs ranges from 15.8% to 57% in the literature, and the agreement among techni...
05
DOI 10.1111/his.70292
Open DOI
Digital analysis of spatial expression of stromal fibroblast activation protein alpha (FAP) in DCIS
Introduction: The presence of non‐progressing ductal carcinoma in situ (DCIS) cases has raised concerns of overtreatment, necessitating comprehensive risk prediction. The tumour microenvironment, especially cancer‐associated fibroblasts ...
06
DOI 10.1111/his.70294
Open DOI
Cyclin‐dependent kinase 4/6 ( CDK4 /6) inhibitor‐induced hepatotoxicity and its resolution: a study of seven cases
Aims: Hepatotoxicity is an increasingly recognised and potentially dose‐limiting adverse effect of CDK4/6 inhibitors, but their histopathological spectrum remains incompletely characterised. We aimed to describe the clinicopathological f...
07
DOI 10.1111/his.70295
Open DOI
Do alternative classification systems improve prognostication in phyllodes tumours of the breast? A comparative clinicopathological study
Aims: Phyllodes tumours of the breast (PTs) present complex histological features that challenge classification. The WHO 5th Edition (2019) defines malignancy based on five simultaneous criteria, which may under‐recognize tumours with me...
08
09
DOI 10.1111/his.70293
Open DOI
Mitoses counting in phyllodes tumours: rationale for a standardized hotspot‐based approach
Background: Breast phyllodes tumours (PTs) are rare biphasic fibroepithelial neoplasms, classified into benign, borderline and malignant categories. Stromal mitotic activity is a key criterion in grading PT, but the methodology for mitot...
10
DOI 10.1111/his.70296
Open DOI
A rare postradiation vaginal vascular lesion: not an angiosarcoma
Bibliographical & Catalog Notes
Also issued online.
Official journal of the British Division of the International Academy of Pathology.
Vol. 4, no. 1 (1980)19920818 Notice not published Printed on acid-free paper